Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2018 08:30 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that based on...
January 03, 2018 09:25 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
December 15, 2017 16:04 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Ltd. (Nasdaq:OXFD) and QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt Stock Exchange:QIA) announced today that...
November 21, 2017 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
November 10, 2017 09:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
October 31, 2017 07:00 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Reports Third Quarter 2017 Financial Results

Third quarter revenue of $30.4 million, an increase of 17% compared to prior year periodContinued growth from both the Tuberculosis (TB) and Tick-borne disease franchises, with double-digit revenue...
October 17, 2017 09:15 ET | Source: Oxford Immunotec Global PLC

Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing...
September 27, 2017 09:25 ET | Source: Oxford Immunotec

Oxford Immunotec Announces Update in Patent Infringement Litigation

OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
August 30, 2017 16:15 ET | Source: Oxford Immunotec

Oxford Immunotec to Present at the Baird 2017 Global Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
August 30, 2017 09:00 ET | Source: Oxford Immunotec

Oxford Immunotec Appoints Stefan Linn as Chief Operating Officer

OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...